The Institute for Neurodegenerative Disorders

10/09/2026

“This is precision medicine in Parkinson's disease.” — Dr. Thomas Tropea
What if a blood test could help researchers better understand who is at greater risk of developing dementia in Parkinson's disease?
A new study led by Dr. Thomas Tropea offers a promising glimpse of how that might become possible.
The study found that higher levels of a protein called P-tau217 in the blood were associated with a greater risk of cognitive decline in people with Parkinson's disease.
These findings could help researchers identify people at higher risk and design more focused clinical trials, moving Parkinson's research toward approaches that account for individual differences.
Research led by IND’s Dr. Thomas Tropea was recently highlighted by Dr. Connie Marras during the “Essential Highlights in Movement Disorders” session at the International Parkinson and Movement Disorder Society (MDS) Congress, bringing attention to its potential significance for the future of Parkinson's research.

Read the study, published in Annals of Neurology: https://pubmed.ncbi.nlm.nih.gov/41848292/



International Parkinson and Movement Disorder Society

10/07/2026

Progressive Supranuclear Palsy (PSP) is a rare neurodegenerative condition, and there is still much to learn about what is happening in the brain.
IND is seeking adults ages 45–85 who have been diagnosed with PSP for specialized brain imaging research studies. The studies use PET imaging to help researchers better understand changes associated with PSP.
You could help us see even more.
If you’d like to learn more about participating, complete our brief interest form.
https://bit.ly/INDRedcap-FB

10/05/2026

Multiple System Atrophy (MSA) is a rare neurodegenerative condition that can affect multiple systems throughout the body, including movement, balance, speech and swallowing, blood pressure, digestion, and bladder function.
At IND, we're conducting clinical research focused on MSA.
If you'd like to learn more about current MSA research studies at IND, complete our brief interest form: https://bit.ly/INDRedcap-FB

10/03/2026

On World MSA Day, we recognize people living with multiple system atrophy and the families and care partners alongside them.
To everyone navigating the uncertainty of MSA: you deserve to be seen, heard, and supported.

09/28/2026

Meet Dr. Thomas Tropea, IND’s Chief Medical Officer.
His research focuses on Parkinson’s disease, biomarkers, and precision medicine — helping advance the way Parkinson’s and related disorders are studied and understood.
We’re excited to feature him in our Meet Our Doctors series.

09/21/2026

Today, on World Alzheimer’s Day, we recognize people living with Alzheimer’s disease and the families, caregivers, clinicians, and researchers alongside them.
Alzheimer’s disease is the most common cause of dementia. Continued awareness, earlier diagnosis, and scientific research are essential to improving the lives of those affected.
Today, we join the global community in recognizing the need for greater understanding, support and progress.

09/16/2026

We’re pleased to welcome David S. Russell, MD, PhD, to his new role at the Institute for Neurodegenerative Disorders (IND) as Senior Director, Clinical Research.
Dr. Russell brings extensive experience in clinical research, neurodegenerative disease biomarkers and imaging, with work spanning Parkinson’s disease, Alzheimer’s disease and other neurodegenerative disorders.
We look forward to the expertise and perspective Dr. Russell brings to IND’s research community.
Please join us in welcoming Dr. Russell to his new role at IND!

09/09/2026

Healthy men may qualify for a paid clinical research study.
The Institute for Neurodegenerative Disorders (IND) is seeking healthy adult males, ages 18–55, for a clinical research study in New Haven, Connecticut.
Swipe through to learn who may qualify, what's involved, and what to expect.
To learn more and see if you may qualify, complete our brief interest survey using the link https://bit.ly/INDRedcap-FB

09/07/2026

Are you on Reddit? Come visit our new page and be part of the conversation.

Explore IND_Research’s posts and comments on Reddit

09/02/2026

Healthy men may qualify for a paid clinical research study.
The Institute for Neurodegenerative Disorders (IND) is seeking healthy adult males, ages 18–55, for a clinical research study in New Haven, Connecticut.
Swipe through to learn who may qualify, what's involved, and what to expect.
To learn more and see if you may qualify, complete our brief interest survey using the link: https://bit.ly/INDRedcap-FB